Facebook Linkedin RSS Twitter Youtube
Home 2025

Drug research and development

2025 Trends: Organoids
Artificial Intelligence

2025 Trends: Organoids

AI Accelerates and Expands Drug Development
Artificial Intelligence

AI Accelerates and Expands Drug Development

Ketamine Reduces L-DOPA-Related Uncontrolled Movements in Parkinson’s Rat Model
Featured

Ketamine Reduces L-DOPA-Related Uncontrolled Movements in Parkinson’s Rat Model

From Promise to Practice: Danaher Gathers Visionaries to Discuss AI-Driven R&D
Artificial Intelligence

From Promise to Practice: Danaher Gathers Visionaries to Discuss AI-Driven R&D

Running Up That Hill: An Interview with Carole Ho, Denali Therapeutics
Insights

Running Up That Hill: An Interview with Carole Ho, Denali Therapeutics

Accelerating Bispecific Antibody Discovery: From Antigens to Lead Panels in Just Four Months
Bioprocessing

Accelerating Bispecific Antibody Discovery: From Antigens to Lead Panels in Just Four Months

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary
Bioprocessing

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma
Cancer

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

S. aureus Vaccine Failures Linked to Interleukin Production, Antibody Inactivation
Drug Discovery

S. aureus Vaccine Failures Linked to Interleukin Production, Antibody Inactivation

StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results
Drug Discovery

StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results

123...912Page 2 of 912
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.